Business
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
LAVAL, QC / ACCESSWIRE / February 1, 2024 / Bausch Health Companies Inc. (NYSE/TSX:BHC) will rel...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22LAVAL, QC / ACCESSWIRE / February 1, 2024 / Bausch Health Companies Inc. (NYSE/TSX:BHC) will release fourth-quarter and full-year 2023 financial results on Thursday, Feb. 22, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.Conference Call DetailsDate:Thursday, Feb. 22, 2024Time:8:00 a.m. U.S. ESTWebcast:http://ir.bauschhealth.com/events-and-presentationsA replay of the conference call will be available on the investor relations website.To participate in the live Q&A session, please register using this link to receive a PIN, which will be sent an hour before the conference call.About Bausch HealthBausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health outcomes. We develop, manufacture and market a range of products, primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals, and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.Investor Contact:Media Contact:[email protected] Wiggins(877) 281-6642 (toll-free)[email protected] (908) 541-3785SOURCE: Bausch Health Companies Inc.View the original press release on accesswire.com\n","length":3830,"tagName":"div"}]